AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Clinical trial NCT07619313 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07619313
Sponsor: Jonsson Comprehensive Cancer Center
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Borderline Resectable Pancreatic Ductal Adenocarcinoma Locally Advanced Cholangiocarcinoma Locally Advanced Pancreatic Adenocarcinoma Metastatic Cholangiocarcinoma Metastatic Pancreatic Adenocarcinoma Stage II Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2026-06-01
Primary completion: 2027-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.